BIIB vs CIIT · P/E 21, rev $9.89B vs rev $9.3M
Biogen Inc (BIIB) versus Tianci International, Inc. Common Stock (CIIT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Tianci International, Inc. Common Stock (CIIT) is a integrated freight & logistics company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CIIT revenue for 2025-07-31 was $9.3M. Net income was -$2.7M. CIIT currently screens at market cap $2.1M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CIIT currently screens at market cap $2.1M.
Not investment advice. Open the BIIB and CIIT stock pages for the full models.
Not investment advice.